🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to estimate the efficacy of axicabta...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2019-11-05
Trial ID
NCT04002401
Treatments Being Tested
This is an open label, non-randomized, phase 1 study of anti-CD19 CAR-T cel...
Status
Recruiting
Location
Huntsman Cancer Institute
Start Date
2024-02-20
Trial ID
NCT06227026
Treatments Being Tested
The goal of this phase I/II clinical trial is to compare B-cell depletion b...
Status
Active Not Recruiting
Location
Charité - Universitätsmedizin Berlin
Start Date
2024-12-04
Trial ID
NCT06475495
Treatments Being Tested
The investigators will conduct a phase II clinical trial of autologous muri...
Status
Completed
Location
Beijing Boren Hospital
Start Date
2022-03-24
Trial ID
NCT04325841
Treatments Being Tested
The goal of this clinical study is test how well the study drug, axicabtage...
Status
Active Not Recruiting
Location
City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
Start Date
2022-09-22
Trial ID
NCT05371093
This is an investigator-initiated trial to evaluate the safety and efficacy...
Status
Unknown
Location
Shanghai ChangZheng hospital
Start Date
2024-04-20
Trial ID
NCT06373081
Treatments Being Tested
This study will be separated into 3 distinct phases designated as the Phase...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2015-04-21
Trial ID
NCT02348216
The goal of this clinical study is to compare the study drug, axicabtagene ...
Status
Active Not Recruiting
Location
University of Alabama Hospital
Start Date
2023-02-10
Trial ID
NCT05605899
This is an open-label, four-cohort, phase 2 study to determine the efficacy...
Status
Recruiting
Location
Children's Hospital of Philadelphia
Start Date
2020-03-12
Trial ID
NCT04276870
Treatments Being Tested
Phase IIa study to estimate the efficacy of a single infusion of autologous...
Status
Completed
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2014-02-05
Trial ID
NCT02030834
Treatments Being Tested